243 related articles for article (PubMed ID: 34022796)
21. Vonoprazan versus proton pump inhibitors for postendoscopic submucosal dissection bleeding in the stomach: a multicenter population-based comparative study.
Shiratori Y; Niikura R; Ishii N; Ikeya T; Honda T; Hasatani K; Yoshida N; Nishida T; Sumiyoshi T; Kiyotoki S; Arai M; Kawai T; Fukuda K
Gastrointest Endosc; 2022 Jan; 95(1):72-79.e3. PubMed ID: 34237329
[TBL] [Abstract][Full Text] [Related]
22. Effect of lansoprazole versus roxatidine on prevention of bleeding and promotion of ulcer healing after endoscopic submucosal dissection for superficial gastric neoplasia.
Imaeda H; Hosoe N; Suzuki H; Saito Y; Ida Y; Nakamura R; Iwao Y; Ogata H; Hibi T
J Gastroenterol; 2011 Nov; 46(11):1267-72. PubMed ID: 21805066
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the efficacy of 4- and 8-week lansoprazole treatment for ESD-induced gastric ulcers: a randomized, prospective, controlled study.
Park JH; Baek EK; Choi CH; Lee KH; Kim BJ; Kim JW; Kim JG; Chang SK
Surg Endosc; 2014 Jan; 28(1):235-41. PubMed ID: 23996340
[TBL] [Abstract][Full Text] [Related]
24. Vonoprazan vs proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: A meta-analysis of randomized controlled trials and observational studies.
Martin ; Zhou Y; Meng CX; Takagi T; Tian YS
Medicine (Baltimore); 2020 Feb; 99(9):e19357. PubMed ID: 32118778
[TBL] [Abstract][Full Text] [Related]
25. Is proton-pump inhibitor effective in preventing postoperative bleeding after esophageal endoscopic submucosal dissection?
Tanaka I; Tarasawa K; Saito H; Hirasawa D; Fujimori K; Fushimi K; Matsuda T
Dis Esophagus; 2024 Jan; 37(2):. PubMed ID: 37815127
[TBL] [Abstract][Full Text] [Related]
26. Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers - results from two phase 3, non-inferiority randomised controlled trials.
Miwa H; Uedo N; Watari J; Mori Y; Sakurai Y; Takanami Y; Nishimura A; Tatsumi T; Sakaki N
Aliment Pharmacol Ther; 2017 Jan; 45(2):240-252. PubMed ID: 27891632
[TBL] [Abstract][Full Text] [Related]
27. Vonoprazan versus proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: Protocol for meta-analysis of randomized controlled trials and observational studies.
Martin ; Zhou Y; Meng CX; Takagi T; Tian YS
Medicine (Baltimore); 2019 Feb; 98(8):e14381. PubMed ID: 30813139
[TBL] [Abstract][Full Text] [Related]
28. Risk Factors for Delayed Ulcer Healing after Endoscopic Submucosal Dissection of Gastric Neoplasms.
Shimozato A; Sasaki M; Ogasawara N; Funaki Y; Ebi M; Tamura Y; Izawa S; Hijikata Y; Yamaguchi Y; Kasugai K
J Gastrointestin Liver Dis; 2017 Dec; 26(4):363-368. PubMed ID: 29253050
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers.
Takayama M; Matsui S; Kawasaki M; Asakuma Y; Sakurai T; Kashida H; Kudo M
World J Gastroenterol; 2013 Sep; 19(34):5706-12. PubMed ID: 24039365
[TBL] [Abstract][Full Text] [Related]
30. Optimal duration of proton pump inhibitor in the treatment of endoscopic submucosal dissection-induced ulcers: a retrospective analysis and prospective validation study.
Lee SH; Lee CK; Chung IK; Shim YS; Lee TH; Lee SH; Kim HS; Park SH; Kim SJ
Dig Dis Sci; 2012 Feb; 57(2):429-34. PubMed ID: 22001942
[TBL] [Abstract][Full Text] [Related]
31. Treatment with vonoprazan for 3 weeks is not inferior to 8 weeks for the management of gastric ESD: a multicenter noninferiority randomized study.
Kato M; Hosoe N; Gotoda T; Kusano C; Kuramochi M; Yoshida H; Kimoto Y; Okamura Y; Imaeda H; Ito T; Miyamoto Y; Horii T; Mori H; Morohoshi Y; Ohno A; Kishino R; Kubosawa Y; Yoshimura K; Yahagi N; Kanai T
J Gastroenterol; 2023 Apr; 58(4):358-366. PubMed ID: 36781490
[TBL] [Abstract][Full Text] [Related]
32. Dose-related healing of artificial ulcers after endoscopic submucosal dissection using esomeprazole: A randomized controlled study.
Ko J; Kim SJ; Kang DH; Choi CW; Kim HW; Park SB
Medicine (Baltimore); 2019 May; 98(20):e15701. PubMed ID: 31096515
[TBL] [Abstract][Full Text] [Related]
33. Effects of Vonoprazan Compared with Esomeprazole on the Healing of Artificial Postendoscopic Submucosal Dissection Ulcers: A Prospective, Multicenter, Two-Arm, Randomized Controlled Trial.
Ishii Y; Yamada H; Sato T; Sue S; Kaneko H; Irie K; Sasaki T; Tamura T; Ikeda R; Fukuchi T; Kobayashi R; Makazu M; Sato C; Hirasawa K; Kondo M; Shibata W; Maeda S
Gastroenterol Res Pract; 2018; 2018():1615092. PubMed ID: 29670650
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the Use of Vonoprazan and Proton Pump Inhibitors for the Treatment of Peptic Ulcers Resulting from Endoscopic Submucosal Dissection: A Systematic Review and Meta-Analysis.
He HS; Li BY; Chen QT; Song CY; Shi J; Shi B
Med Sci Monit; 2019 Feb; 25():1169-1176. PubMed ID: 30755541
[TBL] [Abstract][Full Text] [Related]
35. Incidence of Delayed Bleeding among Patients Continuing Antithrombotics during Gastric Endoscopic Submucosal Dissection.
Kakushima N; Ono H; Takizawa K; Tanaka M; Kawata N; Yoshida M; Murai K; Yabuuchi Y; Kishida Y; Ito S; Imai K; Hotta K; Ishiwatari H; Matsubayashi H
Intern Med; 2019; 58(19):2759-2766. PubMed ID: 31582592
[TBL] [Abstract][Full Text] [Related]
36. Basal protrusion of ulcers induced by endoscopic submucosal dissection (ESD) during treatment with proton pump inhibitors, and the suppressive effects of polaprezinc.
Inaba T; Ishikawa S; Toyokawa T; Ishikawa H; Miyahara K; Wato M; Kawai K; Okada H; Yamamoto K
Hepatogastroenterology; 2010; 57(99-100):678-84. PubMed ID: 20698249
[TBL] [Abstract][Full Text] [Related]
37. Prospective single-arm trial of two-week rabeprazole treatment for ulcer healing after gastric endoscopic submucosal dissection.
Niimi K; Fujishiro M; Goto O; Kodashima S; Minatsuki C; Hirayama I; Mochizuki S; Ono S; Yamamichi N; Kakushima N; Ichinose M; Koike K
Dig Endosc; 2012 Mar; 24(2):110-6. PubMed ID: 22348835
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with healing of artificial ulcer after endoscopic submucosal dissection with reference to Helicobacter pylori infection, CYP2C19 genotype, and tumor location: Multicenter randomized trial.
Yoshizawa Y; Sugimoto M; Sato Y; Sahara S; Ichikawa H; Kagami T; Hosoda Y; Kimata M; Tamura S; Kobayashi Y; Osawa S; Sugimoto K; Miyajima H; Furuta T
Dig Endosc; 2016 Mar; 28(2):162-72. PubMed ID: 26331711
[TBL] [Abstract][Full Text] [Related]
39. A Multicenter, Randomized, Controlled Trial of Rebamipide Plus Lansoprazole for the Treatment of Postendoscopic Submucosal Dissection Ulcers.
Yan B; Lu Z; Ge Z; Liu S; Guo X; Tian D; Yang Y; Li X; Gong W; Liu Z; Liu M; Zhou B; Zhao K; Pan F; Yang J; Yang Y
Clin Transl Gastroenterol; 2019 Jan; 10(1):e00008. PubMed ID: 30702488
[TBL] [Abstract][Full Text] [Related]
40. Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis.
Xiao Y; Zhang S; Dai N; Fei G; Goh KL; Chun HJ; Sheu BS; Chong CF; Funao N; Zhou W; Chen M
Gut; 2020 Feb; 69(2):224-230. PubMed ID: 31409606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
